Although other components of the metabolic syndrome that underlies T2DM can act as determinants of CVD, this is the first demonstration that serum albumin can modulate lipid flux in macrophages, and that this is under the direct influence of glycemic control in subjects with DM. This evidence concerns the gene ALB and metabolic syndrome.